<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font25">the </span>
   <span class="font15">with </span>
   <span class="font14">for </span>
   <span class="font13">(). </span>
   <span class="font12">which </span>
   <span class="font12">viral </span>
   <span class="font12">are </span>
   <span class="font12">patients </span>
   <span class="font12">from </span>
   <span class="font12">that </span>
   <span class="font11">also </span>
   <span class="font11">cell </span>
   <span class="font11">protein </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">was </span>
   <span class="font11">arginine </span>
   <span class="font11">antiviral </span>
   <span class="font11">respiratory </span>
   <span class="font11">immune </span>
   <span class="font11">ARDS </span>
   <span class="font11">cells </span>
   <span class="font11">host </span>
   <span class="font11">associated </span>
   <span class="font11">infection </span>
   <span class="font11">The </span>
   <span class="font11">COVID- </span>
   <span class="font11">can </span>
   <span class="font11">coronavirus </span>
   <span class="font11">virus </span>
   <span class="font11">has </span>
   <span class="font11">increased </span>
   <span class="font11">severe </span>
   <span class="font10">acute </span>
   <span class="font10">its </span>
   <span class="font10">via </span>
   <span class="font10">{background </span>
   <span class="font10">(); </span>
   <span class="font10">ACE </span>
   <span class="font10">ascorbate </span>
   <span class="font10">receptor </span>
   <span class="font10">were </span>
   <span class="font10">important </span>
   <span class="font10">(), </span>
   <span class="font10">RNA </span>
   <span class="font10">inhibitors </span>
   <span class="font10">not </span>
   <span class="font10">replication </span>
   <span class="font10">IFN </span>
   <span class="font10">administration </span>
   <span class="font10">production </span>
   <span class="font10">this </span>
   <span class="font10">activation </span>
   <span class="font10">human </span>
   <span class="font10">levels </span>
   <span class="font10">neutrophil </span>
   <span class="font10">syndrome </span>
   <span class="font10">but </span>
   <span class="font10">have </span>
   <span class="font10">protease </span>
   <span class="font10">response </span>
   <span class="font10">actions </span>
   <span class="font10">fusion </span>
   <span class="font10">margin </span>
   <span class="font10">proteins </span>
   <span class="font10">kinase </span>
   <span class="font10">other </span>
   <span class="font10">{border-style </span>
   <span class="font10">clinical </span>
   <span class="font10">lung </span>
   <span class="font10">shown </span>
   <span class="font10">CoV </span>
   <span class="font10">SARS </span>
   <span class="font10">inhibitor </span>
   <span class="font10">innate </span>
   <span class="font10">pathways </span>
   <span class="font10">px;} </span>
   <span class="font10">their </span>
   <span class="font10">treatment </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">drugs </span>
   <span class="font10">more </span>
   <span class="font10">binding </span>
   <span class="font10">decreased </span>
   <span class="font10">distress </span>
   <span class="font10">during </span>
   <span class="font10">had </span>
   <span class="font10">high </span>
   <span class="font10">inhibits </span>
   <span class="font10">known </span>
   <span class="font10">risk </span>
   <span class="font10">analysis </span>
   <span class="font10">between </span>
   <span class="font10">both </span>
   <span class="font10">early </span>
   <span class="font10">signaling </span>
   <span class="font10">activity </span>
   <span class="font10">after </span>
   <span class="font10">essential </span>
   <span class="font10">expression </span>
   <span class="font10">higher </span>
   <span class="font10">including </span>
   <span class="font10">membrane </span>
   <span class="font10">mortality </span>
   <span class="font10">septic </span>
   <span class="font10">while </span>
   <span class="font10">acid </span>
   <span class="font10">different </span>
   <span class="font10">entry </span>
   <span class="font10">found </span>
   <span class="font10">increase </span>
   <span class="font10">low </span>
   <span class="font10">may </span>
   <span class="font10">multiple </span>
   <span class="font10">showed </span>
   <span class="font10">through </span>
   <span class="font10">use </span>
   <span class="font10">Care </span>
   <span class="font10">IL-, </span>
   <span class="font10">MAVS </span>
   <span class="font10">cellular </span>
   <span class="font10">especially </span>
   <span class="font10">novel </span>
   <span class="font10">patients, </span>
   <span class="font10">used </span>
   <span class="font10">(,). </span>
   <span class="font10">IFN-Î³ </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">another </span>
   <span class="font10">chronic </span>
   <span class="font10">data </span>
   <span class="font10">effect </span>
   <span class="font10">factors </span>
   <span class="font10">inflammation </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibition </span>
   <span class="font10">mice </span>
   <span class="font10">oxide </span>
   <span class="font10">role </span>
   <span class="font10">sepsis </span>
   <span class="font10">such </span>
   <span class="font10">tissue </span>
   <span class="font10">Med </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">activated </span>
   <span class="font10">administered </span>
   <span class="font10">cells, </span>
   <span class="font10">critically </span>
   <span class="font10">disease </span>
   <span class="font10">enzyme </span>
   <span class="font10">epithelial </span>
   <span class="font10">factor </span>
   <span class="font10">gene </span>
   <span class="font10">infections </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibited </span>
   <span class="font10">interferon </span>
   <span class="font10">into </span>
   <span class="font10">involved </span>
   <span class="font10">macrophages </span>
   <span class="font10">need </span>
   <span class="font10">number </span>
   <span class="font10">only </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">proliferation </span>
   <span class="font10">site </span>
   <span class="font10">specific </span>
   <span class="font10">synthesis </span>
   <span class="font10">they </span>
   <span class="font10">vascular </span>
   <span class="font10">RAS </span>
   <span class="font10">benefit </span>
   <span class="font10">docking </span>
   <span class="font10">drug </span>
   <span class="font10">effects </span>
   <span class="font10">either </span>
   <span class="font10">function </span>
   <span class="font10">genes </span>
   <span class="font10">ill </span>
   <span class="font10">induced </span>
   <span class="font10">infection, </span>
   <span class="font10">lethal </span>
   <span class="font10">modifications </span>
   <span class="font10">natural </span>
   <span class="font10">new </span>
   <span class="font10">pulmonary </span>
   <span class="font10">spike </span>
   <span class="font10">these </span>
   <span class="font10">two </span>
   <span class="font10">very </span>
   <span class="font10">./chemrxiv..v </span>
   <span class="font10">Sci </span>
   <span class="font10">against </span>
   <span class="font10">all </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">better </span>
   <span class="font10">care </span>
   <span class="font10">chloroquine </span>
   <span class="font10">combination </span>
   <span class="font10">decrease </span>
   <span class="font10">due </span>
   <span class="font10">first </span>
   <span class="font10">functions </span>
   <span class="font10">genetic </span>
   <span class="font10">hemoglobin </span>
   <span class="font10">hypoxia </span>
   <span class="font10">influenza </span>
   <span class="font10">intensive </span>
   <span class="font10">intracellular </span>
   <span class="font10">likely </span>
   <span class="font10">mechanism </span>
   <span class="font10">metabolism </span>
   <span class="font10">mitochondrial </span>
   <span class="font10">most </span>
   <span class="font10">much </span>
   <span class="font10">px; </span>
   <span class="font10">study </span>
   <span class="font10">surface </span>
   <span class="font10">than </span>
   <span class="font10">type </span>
   <span class="font10">where </span>
   <span class="font10">{font-family </span>
   <span class="font10">(-.) </span>
   <span class="font10">ARDS, </span>
   <span class="font10">Biol </span>
   <span class="font10">However, </span>
   <span class="font10">IDO </span>
   <span class="font10">IL- </span>
   <span class="font10">L-arginine </span>
   <span class="font10">TLR </span>
   <span class="font10">action </span>
   <span class="font10">actions. </span>
   <span class="font10">adaptive </span>
   <span class="font10">amino </span>
   <span class="font10">and/or </span>
   <span class="font10">angiotensin </span>
   <span class="font10">approved </span>
   <span class="font10">blocking </span>
   <span class="font10">blocks </span>
   <span class="font10">cleavage </span>
   <span class="font10">compounds </span>
   <span class="font10">critical </span>
   <span class="font10">doses </span>
   <span class="font10">endosomal </span>
   <span class="font10">endothelial </span>
   <span class="font10">evaluation </span>
   <span class="font10">followed </span>
   <span class="font10">font-size </span>
   <span class="font10">heme </span>
   <span class="font10">however, </span>
   <span class="font10">immunity </span>
   <span class="font10">improved </span>
   <span class="font10">increases </span>
   <span class="font10">individuals </span>
   <span class="font10">lymphocyte </span>
   <span class="font10">main </span>
   <span class="font10">molecular </span>
   <span class="font10">molecules </span>
   <span class="font10">necessary </span>
   <span class="font10">nitric </span>
   <span class="font10">possible </span>
   <span class="font10">potent </span>
   <span class="font10">potential </span>
   <span class="font10">production, </span>
   <span class="font10">proteases </span>
   <span class="font10">receptors </span>
   <span class="font10">reduced </span>
   <span class="font10">replication, </span>
   <span class="font10">responses </span>
   <span class="font10">significant </span>
   <span class="font10">stimulates </span>
   <span class="font10">therapeutic </span>
   <span class="font10">there </span>
   <span class="font10">trials </span>
   <span class="font10">when </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">-day </span>
   <span class="font10">Acad </span>
   <span class="font10">Another </span>
   <span class="font10">Arginine </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Low </span>
   <span class="font10">MERS </span>
   <span class="font10">Mol </span>
   <span class="font10">ORF </span>
   <span class="font10">Respir </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">Table </span>
   <span class="font10">[], </span>
   <span class="font10">accessory </span>
   <span class="font10">activation, </span>
   <span class="font10">airway </span>
   <span class="font10">arginine-ascorbate </span>
   <span class="font10">based </span>
   <span class="font10">being </span>
   <span class="font10">block </span>
   <span class="font10">case </span>
   <span class="font10">days </span>
   <span class="font10">degradation </span>
   <span class="font10">dendritic </span>
   <span class="font10">double; </span>
   <span class="font10">effective </span>
   <span class="font10">excessive </span>
   <span class="font10">forms </span>
   <span class="font10">further </span>
   <span class="font10">iNOS </span>
   <span class="font10">impaired </span>
   <span class="font10">inflammatory </span>
   <span class="font10">injury </span>
   <span class="font10">lower </span>
   <span class="font10">many </span>
   <span class="font10">needed </span>
   <span class="font10">observation </span>
   <span class="font10">one </span>
   <span class="font10">orf </span>
   <span class="font10">pathway </span>
   <span class="font10">patient </span>
   <span class="font10">pneumonia </span>
   <span class="font10">present </span>
   <span class="font10">proposed </span>
   <span class="font10">responses, </span>
   <span class="font10">results </span>
   <span class="font10">same </span>
   <span class="font10">seen </span>
   <span class="font10">significantly </span>
   <span class="font10">since </span>
   <span class="font10">small </span>
   <span class="font10">survival </span>
   <span class="font10">syndrome: </span>
   <span class="font10">system </span>
   <span class="font10">treatments </span>
   <span class="font10">useful </span>
   <span class="font10">-.; </span>
   <span class="font10">-fold </span>
   <span class="font10">Ascorbate </span>
   <span class="font10">Besides </span>
   <span class="font10">Crit </span>
   <span class="font10">For </span>
   <span class="font10">High </span>
   <span class="font10">IFN-I </span>
   <span class="font10">IFNs </span>
   <span class="font10">Natl </span>
   <span class="font10">Protease </span>
   <span class="font10">RIG- </span>
   <span class="font10">RIG-I </span>
   <span class="font10">ROS </span>
   <span class="font10">T-cell </span>
   <span class="font10">There </span>
   <span class="font10">This </span>
   <span class="font10">activates </span>
   <span class="font10">active </span>
   <span class="font10">age </span>
   <span class="font10">allele </span>
   <span class="font10">analyzed </span>
   <span class="font10">apoptosis </span>
   <span class="font10">arginase </span>
   <span class="font10">ascorbate, </span>
   <span class="font10">ascorbic </span>
   <span class="font10">aspects </span>
   <span class="font10">besides </span>
   <span class="font10">bicarbonate </span>
   <span class="font10">bind </span>
   <span class="font10">binds </span>
   <span class="font10">blocked </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bradykinin </span>
   <span class="font10">cells. </span>
   <span class="font10">clearance </span>
   <span class="font10">complex </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">damage </span>
   <span class="font10">dependent </span>
   <span class="font10">difference </span>
   <span class="font10">directly </span>
   <span class="font10">dose </span>
   <span class="font10">efficacy </span>
   <span class="font10">elevated </span>
   <span class="font10">even </span>
   <span class="font10">exposure </span>
   <span class="font10">formation </span>
   <span class="font10">hepatitis </span>
   <span class="font10">highly </span>
   <span class="font10">increasing </span>
   <span class="font10">individual </span>
   <span class="font10">induce </span>
   <span class="font10">infectivity </span>
   <span class="font10">inflammation, </span>
   <span class="font10">macrophages, </span>
   <span class="font10">major </span>
   <span class="font10">membranes </span>
   <span class="font10">metabolic </span>
   <span class="font10">necrosis </span>
   <span class="font10">normal </span>
   <span class="font10">observed </span>
   <span class="font10">physiological </span>
   <span class="font10">populations </span>
   <span class="font10">presence </span>
   <span class="font10">prompt </span>
   <span class="font10">ratio </span>
   <span class="font10">related </span>
   <span class="font10">resulting </span>
   <span class="font10">review </span>
   <span class="font10">serine </span>
   <span class="font10">severity </span>
   <span class="font10">shock </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">stimulated </span>
   <span class="font10">structural </span>
   <span class="font10">suggesting </span>
   <span class="font10">susceptibility </span>
   <span class="font10">synthase </span>
   <span class="font10">testing </span>
   <span class="font10">three </span>
   <span class="font10">vitamin </span>
   <span class="font10">who </span>
   <span class="font10">without </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Review)Int </span>
   <span class="font10">(n=) </span>
   <span class="font10">(type </span>
   <span class="font10">CRP </span>
   <span class="font10">Clin </span>
   <span class="font10">Clinical </span>
   <span class="font10">Docking </span>
   <span class="font10">During </span>
   <span class="font10">East </span>
   <span class="font10">FDA </span>
   <span class="font10">Figure </span>
   <span class="font10">IFN-Î² </span>
   <span class="font10">ISGs </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">MDA </span>
   <span class="font10">MyD </span>
   <span class="font10">NF-ÎºB </span>
   <span class="font10">NOS </span>
   <span class="font10">Rev </span>
   <span class="font10">USA./pnas. </span>
   <span class="font10">acidosis </span>
   <span class="font10">activate </span>
   <span class="font10">admitted </span>
   <span class="font10">already </span>
   <span class="font10">animal </span>
   <span class="font10">antagonist </span>
   <span class="font10">apoptosis, </span>
   <span class="font10">association </span>
   <span class="font10">authors </span>
   <span class="font10">availability </span>
   <span class="font10">before </span>
   <span class="font10">biological </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">cases </span>
   <span class="font10">cathepsin </span>
   <span class="font10">changes </span>
   <span class="font10">chemotaxis </span>
   <span class="font10">collagen </span>
   <span class="font10">compared </span>
   <span class="font10">concentration </span>
   <span class="font10">concentrations </span>
   <span class="font10">contains </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokine </span>
   <span class="font10">cytokines </span>
   <span class="font10">depletion </span>
   <span class="font10">differential </span>
   <span class="font10">dsRNA </span>
   <span class="font10">em; </span>
   <span class="font10">endosomes </span>
   <span class="font10">energy </span>
   <span class="font10">enhances </span>
   <span class="font10">epidemic </span>
   <span class="font10">experience </span>
   <span class="font10">extracellular </span>
   <span class="font10">fatal </span>
   <span class="font10">favors </span>
   <span class="font10">fibrosis </span>
   <span class="font10">fluid </span>
   <span class="font10">functional </span>
   <span class="font10">genome </span>
   <span class="font10">given </span>
   <span class="font10">greatly </span>
   <span class="font10">group </span>
   <span class="font10">helps </span>
   <span class="font10">hyperinflammatory </span>
   <span class="font10">identifies </span>
   <span class="font10">ii) </span>
   <span class="font10">improve </span>
   <span class="font10">inactivation </span>
   <span class="font10">infected </span>
   <span class="font10">infection. </span>
   <span class="font10">initial </span>
   <span class="font10">intravenous </span>
   <span class="font10">involving </span>
   <span class="font10">killer </span>
   <span class="font10">linked </span>
   <span class="font10">markers </span>
   <span class="font10">mediated </span>
   <span class="font10">medical </span>
   <span class="font10">mostly </span>
   <span class="font10">myeloid </span>
   <span class="font10">neutrophils </span>
   <span class="font10">nsp </span>
   <span class="font10">nsps </span>
   <span class="font10">organ </span>
   <span class="font10">outcome </span>
   <span class="font10">outcomes </span>
   <span class="font10">over-activation </span>
   <span class="font10">oxidative </span>
   <span class="font10">pDCs </span>
   <span class="font10">peroxisomal </span>
   <span class="font10">plasma </span>
   <span class="font10">polymorphism </span>
   <span class="font10">porphyrins </span>
   <span class="font10">positive </span>
   <span class="font10">preventing </span>
   <span class="font10">probably </span>
   <span class="font10">progression </span>
   <span class="font10">promotes </span>
   <span class="font10">protects </span>
   <span class="font10">proteins, </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">regulation </span>
   <span class="font10">release </span>
   <span class="font10">repair </span>
   <span class="font10">report </span>
   <span class="font10">resulted </span>
   <span class="font10">selective </span>
   <span class="font10">showing </span>
   <span class="font10">similar </span>
   <span class="font10">suppression </span>
   <span class="font10">system, </span>
   <span class="font10">tested </span>
   <span class="font10">thus </span>
   <span class="font10">transcription </span>
   <span class="font10">transporter </span>
   <span class="font10">using </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro </span>
   <span class="font10">vs. </span>
   <span class="font10">wound </span>
  </p>
 </body>
</html>
